| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Hematology/Oncology, Department of Medicine, University of California, San Diego, School of Medicine, and Veterans Administration Medical Center, La Jolla, California 92093
Cell line (LNPL) was established from a tumor biopsy of a nasopharyngeal "histiocytic" lymphoma composed of large noncleaved B-cells. LNPL expressed immunoglobulin M
surface immunoglobulin, as did the original tumor. LNPL also expressed la antigen but lacked Epstein-Barr virus nuclear antigen. It exhibited a translocation between chromosomes 8 and 14 which has been described in certain other malignant lymphoproliferative disorders. An autologous T-cell line lacked the translocation between chromosomes 8 and 14. LNPL is being used as an immunogen to produce monoclonal antibodies in our laboratory. Such cell lines may facilitate identification of lymphoma-associated surface antigens.
1 Supported by the Veterans Administration, Grant IM 207 of the American Cancer Society, Contract N01-CB-84250-31 of the National Cancer Institute, and NIH Grant PHSHL-07107-05.
2 To whom requests for reprints should be addressed, at Division of Hematology/OncologyV111E, University of California, San Diego, School of Medicine, La Jolla, Calif. 92093.
Received 3/17/81. Accepted 1/ 4/82.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |